Bernstein Maintains a Buy Rating on Novartis (NVS), Sets a CHF108 PT
Novartis AG (NYSE:NVS) is one of the top cheap pharmaceutical stocks to buy now.
Novartis A G (NVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 7,121,414 | $861,762,333 | +6% | 0.34% |
| 2. | Renaissance Technologies Jim Simons | 2,298,151 | $278,099,253 | +1% | 0.37% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,431,814 | $173,263,812 | -1% | 0.2% |
| 4. | Balyasny Asset Management Dmitry Balyasny | 876,956 | $106,120,446 | +53% | 0.16% |
| 5. | Millennium Management Israel Englander | 840,771 | $101,741,699 | +99% | 0.05% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,647,629 | $1,288,469,585 | 0.72% | |
| 2. | 10,401,434 | $1,258,677,530 | 1% | |
| 3. | 9,060,895 | $1,096,395,639 | 0.25% | |
| 4. | 7,559,488 | $914,773,991 | 0.06% | |
| 5. | 5,581,576 | $675,426,544 | 0.85% |
News See All
11 Cheap Pharmaceutical Stocks to Buy Now
The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the steps they should take to decrease the prices of US prescription drugs to “most...
Novartis AG (NVS): Jim Cramer Wonders Whether Its CEO Is Leaving [UPDATED]
Novartis AG (NYSE:NVS) is a Swiss pharmaceutical company that is one of the largest of its kind.
Novartis AG (NYSE:NVS) Q2 2025 Earnings Call Transcript
Operator: Good morning and good afternoon, and welcome to the Novartis Q2 2025 Results Release Conference Call and Live Webcast. [Operator Instructions]. The conference is being recorded.
Kisqali Emerges as Novartis AG (NVS) Blockbuster with Record Q2 Growth
Novartis AG (NYSE:NVS) is a Swiss pharmaceutical leader focused on developing innovative treatments across oncology, immunology, neuroscience, cardiovascular, and renal diseases.
10 Most Undervalued Pharma Stocks to Buy Now
Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs. In 2023, the U.S.
8 Stocks That Jim Cramer Recently Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed what bank industry executives were saying about President Trump removing Federal Reserve Chairman Jerome Powell.
Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion
Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed the acquisition of Regulus Therapeutics.
11 Best European Stocks to Invest In
US stocks don’t always lead. That’s the sentiment echoed across the equity markets as investors increasingly eschew US stocks in favor of international names.
Novartis AG (NVS): A Bull Case Theory
We came across a bullish thesis on Novartis AG (NVS) on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on NVS.